{"id":"https://openalex.org/W7099716379","doi":null,"title":"35 Current Trends in the Management of Chronic Myelogenous Leukemia","display_name":"35 Current Trends in the Management of Chronic Myelogenous Leukemia","alternate_titles":[],"publication_year":null,"publication_date":null,"ids":{"openalex":"https://openalex.org/W7099716379"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.690.4288","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.690.4288","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://apiindia.org/pdf/pg_med_2008/Chapter-35.pdf","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W7099716379"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9879999756813049},{"id":"https://openalex.org/keywords/imatinib-mesylate","display_name":"imatinib mesylate","score":0.8930000066757202},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.7540000081062317},{"id":"https://openalex.org/keywords/bcr-abl-tyrosine-kinase","display_name":"BCR-ABL tyrosine kinase","score":0.7889999747276306},{"id":"https://openalex.org/keywords/philadelphia-chromosome","display_name":"Philadelphia chromosome","score":0.8970000147819519},{"id":"https://openalex.org/keywords/bcr-abl-mutations","display_name":"BCR-ABL mutations","score":0.8069999814033508},{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.8270000219345093},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6639999747276306},{"id":"https://openalex.org/keywords/disease-surveillance","display_name":"disease surveillance","score":0.734000027179718},{"id":"https://openalex.org/keywords/cytogenetics","display_name":"cytogenetics","score":0.8500000238418579},{"id":"https://openalex.org/keywords/quantitative-rt-pcr","display_name":"quantitative RT-PCR","score":0.8790000081062317},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.42100000381469727}],"concepts":[{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.7888000011444092},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.7710000276565552},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.7506999969482422},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7092000246047974},{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.5724999904632568},{"id":"https://openalex.org/C2778904597","wikidata":"https://www.wikidata.org/wiki/Q1129111","display_name":"Philadelphia chromosome","level":4,"score":0.5577999949455261},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5541999936103821},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5498999953269958},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5271999835968018},{"id":"https://openalex.org/C125418893","wikidata":"https://www.wikidata.org/wiki/Q587961","display_name":"ABL","level":4,"score":0.5234000086784363},{"id":"https://openalex.org/C111829193","wikidata":"https://www.wikidata.org/wiki/Q1108970","display_name":"Fusion gene","level":3,"score":0.508899986743927},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5040000081062317},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.438400000333786},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4246000051498413},{"id":"https://openalex.org/C30481170","wikidata":"https://www.wikidata.org/wiki/Q37748","display_name":"Chromosome","level":3,"score":0.4077000021934509},{"id":"https://openalex.org/C174475383","wikidata":"https://www.wikidata.org/wiki/Q246128","display_name":"Cytogenetics","level":4,"score":0.39410001039505005},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.32100000977516174},{"id":"https://openalex.org/C2994225774","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Gene mutation","level":4,"score":0.31940001249313354},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.31290000677108765},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3124000132083893},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.310699999332428},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.30250000953674316},{"id":"https://openalex.org/C41650920","wikidata":"https://www.wikidata.org/wiki/Q14912399","display_name":"CD135","level":4,"score":0.2978000044822693},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2953999936580658},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.29179999232292175},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.287200003862381},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2635999917984009},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.2574000060558319},{"id":"https://openalex.org/C123894998","wikidata":"https://www.wikidata.org/wiki/Q425158","display_name":"Fusion protein","level":4,"score":0.25130000710487366}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.690.4288","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.690.4288","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://apiindia.org/pdf/pg_med_2008/Chapter-35.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1553637433","https://openalex.org/W2035155744","https://openalex.org/W2120517971","https://openalex.org/W1975651533","https://openalex.org/W2197119058","https://openalex.org/W2105763112","https://openalex.org/W2425984512","https://openalex.org/W2066447958","https://openalex.org/W4390477630","https://openalex.org/W2007885715"],"abstract_inverted_index":{"Abstract:":[0],"CML":[1,173],"is":[2,9,75,130,170],"a":[3,79,93],"hematopoietic":[4],"stem":[5],"cell":[6],"disease":[7,198],"which":[8],"characterized":[10],"by":[11],"the":[12,20,35,39,49,60,66,83,99,105,113,131,188,193],"presence":[13,189],"of":[14,38,59,86,90,98,107,146,190],"Philadelphia":[15],"chromosome":[16,46,54],"(Ph-chromosome)":[17],"resulting":[18,64,196],"from":[19,65],"translocation":[21,30,69],"between":[22],"chromosomes":[23],"9":[24],"and":[25,48,74,95,116,167],"22":[26,47],"[t":[27],"(9;22)].":[28],"This":[29],"t":[31,67],"(9;22)":[32,68],"results":[33],"in":[34,82,122,161,172,192,197],"head-to-tail":[36],"fusion":[37,61],"breakpoint":[40],"cluster":[41],"region":[42],"gene":[43,51,62],"(BCR)":[44],"on":[45,53,200],"ABL":[50],"located":[52],"9.":[55],"The":[56,88],"protein":[57],"product":[58],"(bcr-abl)":[63],"has":[70,103],"tyrosine":[71,101],"kinase":[72,102,204],"activity":[73],"believed":[76],"to":[77,174,177,187],"play":[78],"central":[80],"role":[81],"initial":[84,143],"development":[85,89],"CML.":[87,108,127],"imatinib":[91,121],"mesylate,":[92],"potent":[94],"specific":[96],"inhibitor":[97],"bcr-abl":[100],"revolutionized":[104],"treatment":[106,134],"Many":[109],"studies":[110],"have":[111],"established":[112],"safety,":[114],"efficacy":[115],"excellent":[117],"survival":[118],"benefit":[119],"for":[120,135,157],"patients":[123,158,180],"with":[124,165],"newly":[125,136],"diagnosed":[126,137],"Imatinib":[128],"mesylate":[129],"recommended":[132],"first-line":[133],"chronic":[138],"phase":[139],"CML,":[140],"at":[141],"an":[142],"standard":[144],"dose":[145],"400":[147],"mg":[148],"daily.":[149],"Higher":[150],"doses,":[151],"if":[152],"tolerated":[153],"can":[154],"be":[155],"administered":[156],"who":[159],"are":[160],"relapse.":[162],"Disease":[163],"monitoring":[164],"cytogenetics":[166],"quantitative":[168],"RT-PCR":[169],"crucial":[171],"assess":[175],"response":[176],"treatment.":[178],"Some":[179],"will":[181],"eventually":[182],"develop":[183],"secondary":[184],"resistance":[185],"related":[186],"mutation":[191],"BCR-ABL":[194],"gene,":[195],"progression":[199],"imatinib.":[201],"Dasatinib,":[202],"another":[203]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7099716379","counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2025-10-27T00:00:00"}
